Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wolff

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group reportMadan H Jagasia, Hildegard T Greinix, Mukta Arora, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injuryJulius C Fischer, Sascha Göttert, Maximilian Giller, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
Blood|July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group reportMadan H Jagasia, Hildegard T Greinix, Mukta Arora, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injuryJulius C Fischer, Sascha Göttert, Maximilian Giller, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
Blood|July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Pageof 18